Advanced search
Publication Cover
RNA Biology Volume 17, 2020 - Issue 11: Noncoding RNAs as Regulators of Cancer
Submit an article Journal homepage
2,291
Views
7
CrossRef citations to date
0
Altmetric
Point of View

LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy

Sergey D. Egranova Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Qingsong Hua Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Chunru Lina Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;b The Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
&
Liuqing Yanga Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;b The Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;c Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
View further author information
Pages 1625-1627 | Published online: 23 May 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Cuihong Wang, Guanying Yu, Ying Xu, Chengfei Liu, Qian Sun, Wenqing Li, Junhua Sun, Yuhua Jiang & Lan Ye. (2021) Knockdown of Long Non-Coding RNA HCP5 Increases Radiosensitivity Through Cellular Senescence by Regulating microRNA-128 in Gliomas. Cancer Management and Research 13, pages 3723-3737.
Read now

Articles from other publishers (6)

Haotian Zheng, Guanghui Wang, Yadong Wang, Jichang Liu, Guoyuan Ma & Jiajun Du. (2023) Systematic analysis reveals a pan-cancer SNHG family signature predicting prognosis and immunotherapy response. iScience 26:10, pages 108055.
Crossref
Sunny Kumar, Mouli Chatterjee, Pratyasha Ghosh, Kirat K. Ganguly, Malini Basu & Mrinal K. Ghosh. (2023) Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients. Genes & Diseases 10:4, pages 1318-1350.
Crossref
Yuan DengMin XiaoArabella H. WanJiarui LiLei SunHeng LiangQiao-Ping WangSheng YinXianzhang BuGuohui Wan. (2022) RNA and RNA Derivatives: Light and Dark Sides in Cancer Immunotherapy. Antioxidants & Redox Signaling 37:16-18, pages 1266-1290.
Crossref
Hao Zhang, Nan Zhang, Wantao Wu, Ran Zhou, Shuyu Li, Zeyu Wang, Ziyu Dai, Liyang Zhang, Zaoqu Liu, Jian Zhang, Peng Luo, Zhixiong Liu & Quan Cheng. (2022) Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma. Briefings in Bioinformatics 23:6.
Crossref
Sen Hou, Yu-Ying Zhuang, Qiu-Yu Lin, Zhen Chen, Hong-Guang Zhao, Laney Zhang & Cheng-He Lin. (2021) Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma. Experimental and Molecular Pathology 121, pages 104658.
Crossref
Marjan Ostovarpour, Mohammad Khalaj-Kondori & Tayyebeh Ghasemi. (2021) Correlation between expression levels of lncRNA FER1L4 and RB1 in patients with colorectal cancer. Molecular Biology Reports 48:5, pages 4581-4589.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.